Back to Journals » OncoTargets and Therapy » Volume 9

High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy

Total article views   HTML views PDF downloads Totals
9,884 Dovepress* 8,962+ 1,513 10,475
PubMed Central* 922 337 1,259
Totals 9,884 1,850 11,734
*Since 30 December 2015
+Since July 2016

View citations on PubMed Central and Google Scholar